_version_ 1784570491449638912
author Oosting, S.
Van der Veldt, A.A.M.
GeurtsvanKessel, C.H.
Fehrmann, R.S.N.
van Binnendijk, R.S.
Dingemans, A-M.C.
Smit, E.F.F.
Hiltermann, T.J.N.
den Hartog, G.
Jalving, M.
Westphal, T.
Battacharya, A.
van der Heiden, M.
Blank, C.U.
Koopmans, M.P.
van Els, C.A.
Rots, N.Y.
van Baarle, D.
Haanen, J.B.A.G.
de Vries, E.G.
author_facet Oosting, S.
Van der Veldt, A.A.M.
GeurtsvanKessel, C.H.
Fehrmann, R.S.N.
van Binnendijk, R.S.
Dingemans, A-M.C.
Smit, E.F.F.
Hiltermann, T.J.N.
den Hartog, G.
Jalving, M.
Westphal, T.
Battacharya, A.
van der Heiden, M.
Blank, C.U.
Koopmans, M.P.
van Els, C.A.
Rots, N.Y.
van Baarle, D.
Haanen, J.B.A.G.
de Vries, E.G.
author_sort Oosting, S.
collection PubMed
description
format Online
Article
Text
id pubmed-8454422
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher European Society for Medical Oncology. Published by Elsevier Ltd.
record_format MEDLINE/PubMed
spelling pubmed-84544222021-09-21 LBA8 Vaccination against SARS-CoV-2 in patients receiving chemotherapy, immunotherapy, or chemo-immunotherapy for solid tumors Oosting, S. Van der Veldt, A.A.M. GeurtsvanKessel, C.H. Fehrmann, R.S.N. van Binnendijk, R.S. Dingemans, A-M.C. Smit, E.F.F. Hiltermann, T.J.N. den Hartog, G. Jalving, M. Westphal, T. Battacharya, A. van der Heiden, M. Blank, C.U. Koopmans, M.P. van Els, C.A. Rots, N.Y. van Baarle, D. Haanen, J.B.A.G. de Vries, E.G. Ann Oncol SARS-CoV-2 and cancer European Society for Medical Oncology. Published by Elsevier Ltd. 2021-09 2021-09-21 /pmc/articles/PMC8454422/ http://dx.doi.org/10.1016/j.annonc.2021.08.2140 Text en Copyright © 2021 European Society for Medical Oncology. Published by Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle SARS-CoV-2 and cancer
Oosting, S.
Van der Veldt, A.A.M.
GeurtsvanKessel, C.H.
Fehrmann, R.S.N.
van Binnendijk, R.S.
Dingemans, A-M.C.
Smit, E.F.F.
Hiltermann, T.J.N.
den Hartog, G.
Jalving, M.
Westphal, T.
Battacharya, A.
van der Heiden, M.
Blank, C.U.
Koopmans, M.P.
van Els, C.A.
Rots, N.Y.
van Baarle, D.
Haanen, J.B.A.G.
de Vries, E.G.
LBA8 Vaccination against SARS-CoV-2 in patients receiving chemotherapy, immunotherapy, or chemo-immunotherapy for solid tumors
title LBA8 Vaccination against SARS-CoV-2 in patients receiving chemotherapy, immunotherapy, or chemo-immunotherapy for solid tumors
title_full LBA8 Vaccination against SARS-CoV-2 in patients receiving chemotherapy, immunotherapy, or chemo-immunotherapy for solid tumors
title_fullStr LBA8 Vaccination against SARS-CoV-2 in patients receiving chemotherapy, immunotherapy, or chemo-immunotherapy for solid tumors
title_full_unstemmed LBA8 Vaccination against SARS-CoV-2 in patients receiving chemotherapy, immunotherapy, or chemo-immunotherapy for solid tumors
title_short LBA8 Vaccination against SARS-CoV-2 in patients receiving chemotherapy, immunotherapy, or chemo-immunotherapy for solid tumors
title_sort lba8 vaccination against sars-cov-2 in patients receiving chemotherapy, immunotherapy, or chemo-immunotherapy for solid tumors
topic SARS-CoV-2 and cancer
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8454422/
http://dx.doi.org/10.1016/j.annonc.2021.08.2140
work_keys_str_mv AT oostings lba8vaccinationagainstsarscov2inpatientsreceivingchemotherapyimmunotherapyorchemoimmunotherapyforsolidtumors
AT vanderveldtaam lba8vaccinationagainstsarscov2inpatientsreceivingchemotherapyimmunotherapyorchemoimmunotherapyforsolidtumors
AT geurtsvankesselch lba8vaccinationagainstsarscov2inpatientsreceivingchemotherapyimmunotherapyorchemoimmunotherapyforsolidtumors
AT fehrmannrsn lba8vaccinationagainstsarscov2inpatientsreceivingchemotherapyimmunotherapyorchemoimmunotherapyforsolidtumors
AT vanbinnendijkrs lba8vaccinationagainstsarscov2inpatientsreceivingchemotherapyimmunotherapyorchemoimmunotherapyforsolidtumors
AT dingemansamc lba8vaccinationagainstsarscov2inpatientsreceivingchemotherapyimmunotherapyorchemoimmunotherapyforsolidtumors
AT smiteff lba8vaccinationagainstsarscov2inpatientsreceivingchemotherapyimmunotherapyorchemoimmunotherapyforsolidtumors
AT hiltermanntjn lba8vaccinationagainstsarscov2inpatientsreceivingchemotherapyimmunotherapyorchemoimmunotherapyforsolidtumors
AT denhartogg lba8vaccinationagainstsarscov2inpatientsreceivingchemotherapyimmunotherapyorchemoimmunotherapyforsolidtumors
AT jalvingm lba8vaccinationagainstsarscov2inpatientsreceivingchemotherapyimmunotherapyorchemoimmunotherapyforsolidtumors
AT westphalt lba8vaccinationagainstsarscov2inpatientsreceivingchemotherapyimmunotherapyorchemoimmunotherapyforsolidtumors
AT battacharyaa lba8vaccinationagainstsarscov2inpatientsreceivingchemotherapyimmunotherapyorchemoimmunotherapyforsolidtumors
AT vanderheidenm lba8vaccinationagainstsarscov2inpatientsreceivingchemotherapyimmunotherapyorchemoimmunotherapyforsolidtumors
AT blankcu lba8vaccinationagainstsarscov2inpatientsreceivingchemotherapyimmunotherapyorchemoimmunotherapyforsolidtumors
AT koopmansmp lba8vaccinationagainstsarscov2inpatientsreceivingchemotherapyimmunotherapyorchemoimmunotherapyforsolidtumors
AT vanelsca lba8vaccinationagainstsarscov2inpatientsreceivingchemotherapyimmunotherapyorchemoimmunotherapyforsolidtumors
AT rotsny lba8vaccinationagainstsarscov2inpatientsreceivingchemotherapyimmunotherapyorchemoimmunotherapyforsolidtumors
AT vanbaarled lba8vaccinationagainstsarscov2inpatientsreceivingchemotherapyimmunotherapyorchemoimmunotherapyforsolidtumors
AT haanenjbag lba8vaccinationagainstsarscov2inpatientsreceivingchemotherapyimmunotherapyorchemoimmunotherapyforsolidtumors
AT devrieseg lba8vaccinationagainstsarscov2inpatientsreceivingchemotherapyimmunotherapyorchemoimmunotherapyforsolidtumors